Our website have detected that you are using an outdated browser that will prevent you from accessing certain features. Click for more info.
Cart
Su cesta de la compra

Relaciones con Inversores

Aquí encontrarás información, en inglés, para seguir tanto el desarrollo financiero como la dirección estratégica de Zinzino (Información más recién en la parte superior de la página).


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2019

Strong sales growth during November; Zinzino group revenue increased with a total of 30% compared with the previous year. The revenue in November for Zinzino's sales markets increased by 38% to MSEK 69.1 (50.2) due to strong growth foremost in Central Europe. Faun Pharma's external sales decreased by 42% and amounted to MSEK 3.2 (5.5) due to high level of internal production during the month. Overall the Group increased revenues by 30% to MSEK 72.3 (55.7) compared with the previous year. Accumulated revenue for January – November 2019 increased by 30% MSEK 695.8 (534.8). Revenues Más información »

Published: 11 dic. Descargar PDF


ZINZINO AB (PUBL): Zinzino expands in Asia

Zinzino has signed a letter of intent with VMA Life in Singapore regarding the acquisition of this company for a quicker expansion within the Asian region. Zinzino has the intention to sign a final acquisition agreement during the first quarter 2020 after completion of due diligence. VMA Life is a direct sales company with the headquarters in Singapore that has business operations in Malaysia, Thailand, Taiwan, Hong Kong, China and Singapore. VMA Life sells health and beauty products. “With Zinzino we will get a strong partner with great products which we believe will perfectly suit Más información »

Published: 22 nov. Descargar PDF


ZINZINO AB (PUBL): INTERIM REPORT Q3 2019

ZINZINO TOWARDS RECORD YEAR! UPGRADES THE SALESFORCAST TO SEK 750 MILLION Strong growth in Central Europe combined with good development in most other markets contributed to total revenues increasing by 36 % to SEK 186.5 (136.7) million in the third quarter. During the quarter the company launched a redesigned website. The website has been given a new look and feel to reflect the company’s brand. In addition, a new navigation has been introduced and flows around product selection have been simplified. This included a fast, easy and fun shopping experience that makes it easier to Más información »

Published: 15 nov. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2019

Strong sales growth during October; Zinzino group revenue increased with a total of 52% compared with the previous year. The revenue in October for Zinzino's sales markets increased by 55% to MSEK 84.1 (54.1) due to strong growth foremost in Central Europe. Faun Pharma's external sales increased by 3% and amounted to MSEK 4.2 (4.1). Overall the Group increased revenues by 52% to MSEK 88.3 (58.2) compared with the previous year. Accumulated revenue for January – October 2019 increased by 30% MSEK 622.62 (479.1). Revenues distributed as follows: +--------------------+------+------+------ Más información »

Published: 11 nov. Descargar PDF


ZINZINO AB (PUBL): Zinzino and Life Leadership collaborate to provide test-based nutrition to expanding markets

Zinzino announce a new collaboration with the growing Life Leadership Community. Life Leadership is an US based education and savings platform provider that helps customers "Earn and Learn" through their all-in-one digital platform. The “Life App” helps consumers earn cash back on everyday purchases and learn/implement financial and many other life skill principles with their education and tools. Through the Life Leadership mobile shopping platform and peer-to-peer marketing community, Life Leadership will provide access to Zinzino products to their expanding customer base. Más información »

Published: 25 oct. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2019

Strong sales growth during September; Zinzino based revenue increased 41% and the total group revenue with a total of 30% compared with the previous year. Zinzino based revenue for the third quarter 2019 increased with 41% and the total revenue with 35% compared with previous year. The revenue in September for Zinzino's sales markets increased by 41% to MSEK 58.3 (41.4) due to strong growth foremost in Central Europe. Faun Pharma's external sales decreased by 36% and amounted to MSEK 4.1 (6.5) due to high level of internal production during the month. Overall the Group increased revenues by Más información »

Published: 9 oct. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT August 2019

Strong sales growth during August; Zinzino based revenue increased 29% and the total group revenue with a total of 27% compared with the previous year. The revenue in August for Zinzino's sales markets increased by 29% to MSEK 54.3 (41.9) due to strong growth foremost in Central Europe. Faun Pharma's external sales increased by 2% and amounted to MSEK 4.5 (4.4). Overall the Group increased revenues by 27% to MSEK 58.8 (46.4) compared with the previous year.  Accumulated revenue for January – August 2019 increased by 26% MSEK 470.2 (373.6).   Revenues distributed as follows: +-------- Más información »

Published: 12 sep. Descargar PDF


ZINZINO AB (PUBL): INTERIM REPORT Q2 2019

ZINZINO UPGRADES THE SALESFORCAST Strong growth in Central Europe combined with good development in most other markets contributed to total revenues increasing by 23% to SEK 179.5 (145.5) million in the second quarter. During the quarter, a successful launch in Australia was completed and the rapidly rising number of customers and distributors in the market is now establishing a local office in Adelaide. In addition, Zinzino has launched the new product Essent, the next-generation capsule-based dietary supplement in Omega-3, a new and very important product for the North American market. Más información »

Published: 30 ago. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT July 2019

Strong sales growth during July; Zinzino based revenue increased 47% and the total group revenue with a total of 44% compared with the previous year. The revenue in July for Zinzino's sales markets increased by 47% to MSEK 58.1 (39.6) due to strong growth foremost in Central Europe. Faun Pharma's external sales increased by 2% and amounted to MSEK 2.9 (2.8). Overall the Group increased revenues by 44% to MSEK 61.0 (42.4) compared with the previous year.  Accumulated revenue for January – July 2019 increased by 25% MSEK 408.8 (327.2).   Revenues distributed as follows:  +------------- Más información »

Published: 13 ago. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q2 2019

Strong sales growth during June; Zinzino based revenue increased 30% and the total group revenue with a total of 23% compared with the previous year. Zinzino based revenue for the second quarter 2019 increased with 31% and the total revenue with 23% compared with previous year. The revenue in June for Zinzino's sales markets increased by 30% to MSEK 52.4 (40.3) due to strong growth foremost in Central Europe. Faun Pharma's external sales decreased by 23% and amounted to MSEK 4.6 (5.9) due to high level of internal production during the month. Overall the Group increased revenues by 23% to Más información »

Published: 10 jul. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2019

Good sales growth during May; Zinzino based revenue increased 21% and the total group revenue with a total of 10% compared with the previous year. The revenue for Zinzino's sales markets increased by 21% to SEK 58.6 (48.3) million due to strong growth foremost in Central Europe. Faun Pharma's external sales decreased by 58% and amounted to SEK 3.3 (7.8) million due to high level of internal production during the month. Overall. the Group increased revenues by 10 % to SEK 61.9 (56.1) million compared with the previous year. Accumulated income January - May increased by 21% to SEK 287.5 ( Más información »

Published: 12 jun. Descargar PDF


ANNUAL REPORT ENGLISH 2018 ZINZINO AB (PUBL)

Zinzino (publ) announces that the Annual Report for 2018 is now available for download in English at the company’s website, www.zinzino.com.   For more information: Fredrik Nielsen, CFO Zinzino +46 (0) 707 900 174, zinzino.com Pictures for publication free of charge: Marcus Tollbom +46 (0) 70 190 03 12 Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se Más información »

Published: 11 jun. Descargar PDF


ZINZINO AB (PUBL): INTERIM REPORT Q1 – 2019

STRONG SALES GROWTH COMBINED WITH GOOD PROFITABILITY With the support of a new efficient sales-stimulating campaign for the distributor organization, sales growth accelerated during the quarter, which resulted in total revenues increasing by 21% to SEK 168.3 (139.3) million. Strongest growth was found in Central Europe combined with good development in most other markets. The company's digital development continued during the first quarter by fully activating the first part of the new communication platform. Zinzino's investments in IT systems and marketing tools continue to be Más información »

Published: 16 may. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2019

Strong sales growth during April; Zinzino based revenue increased 36% and the total group revenue with a total of 29% compared with the previous year. The revenue for Zinzino's sales markets increased by 36% to SEK 53.4 (39.4) million due to strong growth foremost in Central Europe. Faun Pharma's external sales decreased by 8% and amounted to SEK 6.1 (6.6) million. Overall, the Group increased revenues by 29 % to SEK 59.5 (46.0) million compared with the previous year. Accumulated income January - April increased by 24% to SEK 227.7 (183.7) million compared with the previous year. Más información »

Published: 14 may. Descargar PDF


Annual Report 2018 ZINZINO AB (PUBL)

Zinzino (publ) announces that the Annual Report for 2018 is now published in Swedish at the company’s website, www.zinzino.com. An English version will be published within 45 days. Zinzino will hold the Annual General Meeting on Wednesday May 22nd, 2019 at. 13:30 in the company’s premises at Hulda Mellgrens Gata 5 in Gothenburg. Registration will start at 13:15. For more information: Fredrik Nielsen, CFO Zinzino tfn + 46 (0) 707 900 174, Zinzino.com Pictures for publication free of charge: Marcus Tollbom, Mobile: +46 (0) 70 190 03 12 Certified Adviser:  Erik Penser Bank Aktiebolag, Más información »

Published: 30 abr. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2019

Strong sales growth during March; Zinzino based revenue increased 33% and the total group revenue with a total of 26% compared with the previous year. Zinzino based revenue for the first quarter 2019 increased with 26% and the total revenue with 19% compared with the first quarter the previous year. The revenue for Zinzino's sales markets increased by 33% to SEK 54.1 (40.8) million due to strong growth foremost in the other countries of Europe. Higher share of internal production during the month meant that Faun Pharma's external sales decreased by 33% and amounted to SEK 3.3 (4.8) million. Más información »

Published: 4 abr. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2019

STRONG SALES GROWTH DURING FEBRUARY; ZINZINO BASED REVENUE INCREASED 21% AND THE TOTAL GROUP REVENUE WITH 18% COMPARED WITH THE PREVIOUS YEAR. The revenue for Zinzino's sales markets increasing by 21% to SEK 50.1 (41.4) million. Higher share of internal production during the month meant that Faun Pharma's external sales decreased by 22% and amounted to SEK 2.9 (3.7) million. Overall, the Group increased revenues by 18% to SEK 53.0 (45.1) million compared with the previous year. Accumulated revenues for January-February increased with 16% to 106,5 (91,9) MSEK compared with the previous Más información »

Published: 7 mar. Descargar PDF


ZINZINO AB (PUBL): YEAR-END REPORT 2018

STRONG IMPROVEMENT IN PROFIT POSSIBLE INCREASE SHARE DIVIDEND Improved profit, strong balance sheet and good liquid assets results in the proposal of the board to pay out an ordinary dividend of SEK 0.50 (SEK 45) and an extra dividend of SEK 0.20 (-) to the shareholders for the past year. The increased share of Zinzino Health in the product mix during the year combined with improved cost control resulted in a sharp increase in gross profit. In combination with scaling from other activities, it resulted that the EBITDA increased to SEK 2.2 M (-2.3) for the fourth quarter and doubled Más información »

Published: 28 feb. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2019

STRONG SALES GROWTH DURING JANUARY; REVENUE INCREASED 14% COMPARED WITH THE PREVIOUS YEAR. Growth in all regions resulted in revenues for Zinzino's sales markets increasing by 24% to SEK 49.9 (40.1) million. Higher share of internal production during the month meant that Faun Pharma's external sales decreased by 50% and amounted to SEK 3.3 (6.6) million. Overall, the Group increased revenues by 14% to SEK 53.2 (46.7) million compared with the previous year. Revenues distributed as follows: Regions, SEK million Jan-19 Jan-18 Change Nordic Countries 33,3 35,9 -7% Más información »

Published: 4 feb. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2018

CONSISTENT SALES GROWTH DURING 2018; REVENUE INCREASED 8% COMPARED WITH THE PREVIOUS YEAR. Zinzino’s total revenues for the fourth quarter of 2018 amounted to 164.0 (154.7) MSEK, corresponding to sales growth of 6 % compared to the fourth quarter 2017. Accumulated for 2018, total revenues amounted to 585.6 (540.3) MSEK, corresponding to an increase of 8% compared with the previous year. Revenues distributed as follows: +-------------+-------+-------+----------+-----+-----+----------+ |Regions,MSEK |Q4 2018|Q4 2017|Difference|2018 |2017 |Difference| +-------------+-------+-------+------ Más información »

Published: 29 ene. Descargar PDF


Zinzino AB (PUBL): Interim Report for the third Quarter 2018

Strong growth in combination with a good profitability driven by positive development in Central Europe. Launch of a new digital tool during the third quarter, in combination with Zinzino’s effort of engaging distributors in different markets resulted in a 16% growth in sales compared to the same period last year. The Nordic countries accounted for 70% of the turnover but Germany, Switzerland, Austria, Spain, Rumania and Hungary continue to increase strongly during the third quarter. In addition to investing in the new digital sales tools Zinzino has expanded the activities in Hungary and Más información »

Published: 15 nov. Descargar PDF


ZINZINO AB (PUBL): THE BOARD DECIDES TO ISSUE 200 000 STOCK OPTIONS

The Board of Directors Zinzino AB (publ) has decided to issue 200,000 stock options with the mandate of the AGM of the Company in 2018-05-15. The right to subscribe for new stock options shall, with exception of shareholders’ preferential rights, only be added to Dr. Paul Clayton, Member of the Zinzino’s Scientific Advisory Board. The reason for the deviation from shareholders’ preferential rights is to create incentives for an important external partner that greatly contributes to the company’s positive development. Subscription of the stock options shall be subscribed by subscription Más información »

Published: 15 oct. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT THIRD QUARTER 2018

INCREASED SALES GROWTH DURING THE THIRD QUARTER; REVENUE INCREASED 16% COMPARED WITH THE PREVIOUS YEAR. Zinzino’s total revenues for the third quarter of 2018 amounted to 139.2 (120.1) MSEK, corresponding to sales growth of 16% compared to the third quarter 2017. Accumulated for January - September 2018, total revenues amounted to 421.1 (385.6) MSEK, corresponding to an increase of 9% compared with the previous year. “We see strong sales growth in many markets driven by our dedicated distributors and the digital shift we carry out,” concludes Dag Bergheim Petersen, CEO Zinzino. For more Más información »

Published: 11 oct. Descargar PDF


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2018

Consistent sales growth during the second quarter; revenue increased 5% compared with the previous year. Zinzino’s total revenues for the second quarter of 2018 amounted to 144.7 (137.3) MSEK, corresponding to sales growth of 5% compared to the second quarter 2017. Accumulated for January - June 2018, total revenues amounted to 282.2 (265.5) MSEK, corresponding to an increase of 6% compared with the previous year. Several markets showed strong growth during the second quarter. The new European markets increased 201% in total. The growth was especially strong in Hungary where the sales Más información »

Published: 5 jul. Descargar PDF